Scottish Study Estimates Risk of Bleeding and Clotting Disorders After AstraZeneca Vaccine

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
A nationwide analysis of over 2.5 million Scottish adults who received a first dose of the Oxford/AstraZeneca or Pfizer/BioNTech vaccine between December 2020 and April 2021 has confirmed a small increased risk of immune thrombocytopenic purpura (ITP) and other bleeding and vascular events associated with the Oxford/AstraZeneca vaccine.

However, the research, published in Nature Medicine, suggests the risks are comparable with those seen with other vaccines, including vaccines against hepatitis B, measles, mumps and rubella, and influenza.

The authors found that Oxford/AstraZeneca was associated with a slightly increased risk of ITP up to 27 days after vaccination. The estimated frequency was 1.13 cases per 100,000 first-dose vaccinations.

Those at greatest risk of ITP tended to be older (median age, ≥69 years old) and had at least one underlying chronic health problem, such as coronary heart disease, diabetes, or chronic kidney disease.

 
I bullied my bestie last week into phoning NHS 111 when she was breathless and fainting. She'd had her 2nd astra zeneca jab 9 days before, and after speaking to the clinician at 111 she was taken to hospital with 2 pulmonary embolisms which had started in her swollen ankle and travelled up before splitting into a clot in each lung. She has Parkinsons and psoraic arthritis and is on lots of medication so she was really a prime candidate for complications. Just glad I was with her and overrode her concerns about "not wanting to bother the NHS"! She has since promised to phone 111 in future 🙂
 
10 days after my first jab my legs and feet were very swollen. I was close to bothering someone about it when it began to subside.
I mentioned it at the second jab - not a flicker of interest, no record was made - good thing it wasn't anything serious......
 
Status
Not open for further replies.
Back
Top